Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2021-09-07 00:00:00 ET · period of report 2021-09-04 · accession 0001179110-21-008662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-07 | 2021-09-04 | HALO | Matsuda Masaru | SVP, GC | M - OptEx | $0.00 | +6,883 | 23.5K | +42% | $0 |
| D | 2021-09-07 | 2021-09-04 | HALO | Matsuda Masaru | SVP, GC | F - Tax | $42.22 | -3,412 | 20.0K | -15% | -$144.1K |
| D | 2021-09-07 | 2021-09-04 | HALO | Matsuda Masaru | SVP, GC | M - OptEx | $0.00 | -6,883 | 6,883 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-04 | M | A | 6,883 | $0.00 | 23,461 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-04 | F | D | 3,412 | $42.22 | 20,049 | D | — | — | (F1) The reported disposition of 3,412 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2021-09-04 | M | D | 6,883 | $0.00 | 6,883 | D | $0.00 · — to — | 6,883 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |